Back to Journals » Cancer Management and Research » Volume 10

Evolution of regorafenib from bench to bedside in colorectal cancer: Is it an attractive option or merely a “me too” drug?

Total article views   HTML views PDF downloads Totals
19,297 Dovepress* 16,065+ 1,761 17,826
PubMed Central* 3,232 676 3,908
Totals 19,297 2,437 21,734
*Since 6 March 2018
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 2 6

View citations on PubMed Central and Google Scholar